menu
    • menu

    Company profile for Bone Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Bone Therapeutics is a leading cell therapy company addressing high unmet medical needs in the field of orthopaedics and bone diseases. Bone Therapeutics has a broad, diversified portfolio of bone cell therapy solutions and viscosupplement in clinical development across a number of disease areas targeting markets with large unmet medical needs and limited innovation. Our technology is based on a unique, proprietary approach to...
    Bone Therapeutics is a leading cell therapy company addressing high unmet medical needs in the field of orthopaedics and bone diseases. Bone Therapeutics has a broad, diversified portfolio of bone cell therapy solutions and viscosupplement in clinical development across a number of disease areas targeting markets with large unmet medical needs and limited innovation. Our technology is based on a unique, proprietary approach to bone regeneration which turns undifferentiated stem cells into “osteoblastic”, or bone-forming cells. These cells can be administered via a minimally invasive procedure, avoiding the need for invasive surgery.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Bone TherapeuticsBelgium Flag
    Country
    Country
    Belgium
    Address
    Address
    rue Auguste Piccard, 37 6041 Gosselies
    Telephone
    Telephone
    +32 (0)71 12.10.00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.bonetherapeutics.com/en
    Linkedin
    Linkedin
    https://www.linkedin.com/company/bone-therapeutics-s-a-
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/bonetherapeutic

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bone Therapeutics' final asset buried after phase 2 fail
    Bone Therapeutics' final asset buried after phase 2 fail

    20 Jun 2023

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/bone-therapeutics-final-asset-buried-after-failure-phase-2-fracture-study

    James Waldron FIERCE BIOTECH
    20 Jun 2023
    Share Share
    Bone Therapeutics breaks off old name, rebrands as BioSenic
    Bone Therapeutics breaks off old name, rebrands as BioSenic

    26 Oct 2022

    // Ben Adams FIERCEPHARMA

    https://www.fiercepharma.com/marketing/bone-therapeutics-breaks-old-name-rebrands-biosenic-biotech-names-change-rage-continues

    Ben Adams FIERCEPHARMA
    26 Oct 2022
    Share Share
    Bone to start a new Euronext equity story with a change of name to BioSenic
    Bone to start a new Euronext equity story with a change of name to BioSenic

    25 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/25/2540442/0/en/Bone-Therapeutics-to-start-a-new-Euronext-equity-story-with-a-change-of-name-to-BioSenic-following-the-acquisition-of-a-majority-participation-of-Medsenic-valued-at-EUR-40-million.html

    GLOBENEWSWIRE
    25 Oct 2022
    Share Share
    Bone Therapeutics provides Third Quarter 2022 Business Update
    Bone Therapeutics provides Third Quarter 2022 Business Update

    21 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/21/2538957/0/en/Bone-Therapeutics-provides-Third-Quarter-2022-Business-Update.html

    GLOBENEWSWIRE
    21 Oct 2022
    Share Share
    Bone Therapeutics SA: Transparency notification received from S.F.P.I/F.P.I.M
    Bone Therapeutics SA: Transparency notification received from S.F.P.I/F.P.I.M

    10 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/11/2531403/0/en/Bone-Therapeutics-SA-Transparency-notification-received-from-S-F-P-I-F-P-I-M.html

    GLOBENEWSWIRE
    10 Oct 2022
    Share Share
    Bone Therapeutics to regain worldwide rights to ALLOB
    Bone Therapeutics to regain worldwide rights to ALLOB

    07 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/07/2530066/0/en/Bone-Therapeutics-to-regain-worldwide-rights-to-ALLOB.html

    GLOBENEWSWIRE
    07 Oct 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search